Cardiff Oncology Stock Price on November 13, 2024
| CRDF Stock | USD 2.61 0.07 2.76% |
If you're considering investing in Cardiff Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cardiff Oncology stands at 2.61, as last reported on the 2nd of December, with the highest price reaching 2.69 and the lowest price hitting 2.57 during the day. Cardiff Oncology appears to be dangerous, given 3 months investment horizon. Cardiff Oncology secures Sharpe Ratio (or Efficiency) of 0.0773, which signifies that the company had a 0.0773% return per unit of risk over the last 3 months. We have found thirty technical indicators for Cardiff Oncology, which you can use to evaluate the volatility of the firm. Please makes use of Cardiff Oncology's Risk Adjusted Performance of 0.0678, downside deviation of 7.41, and Mean Deviation of 3.86 to double-check if our risk estimates are consistent with your expectations.
Cardiff Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cardiff |
Sharpe Ratio = 0.0773
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CRDF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.74 actual daily | 51 51% of assets are less volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Cardiff Oncology is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiff Oncology by adding it to a well-diversified portfolio.
Related Headline
Cognition Therapeutics Headline on 13th of November 2024
Cognition Therapeutics GAAP EPS of -0.25 by seekingalpha.com
Cognition Therapeutics reports Q3 GAAP EPS of -0.25.
Cardiff Oncology Valuation on November 13, 2024
It is possible to determine the worth of Cardiff Oncology on a given historical date. On November 13, 2024 Cardiff was worth 3.16 at the beginning of the trading date compared to the closed value of 2.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardiff Oncology stock. Still, in general, we apply an absolute valuation method to find Cardiff Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardiff Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardiff Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 3.44 | 3.44 | 3.08 | 3.14 | 816,251 | |
11/13/2024 | 3.16 | 3.16 | 2.95 | 2.97 | 843,633 |
| 2.98 | 3.01 | 2.80 | 2.84 | 511,152 |
| Backtest Cardiff Oncology | | | Cardiff Oncology History | | | Cardiff Oncology Valuation | Previous | Next |
Cardiff Oncology Trading Date Momentum on November 13, 2024
| On November 14 2024 Cardiff Oncology was traded for 2.84 at the closing time. The top price for the day was 3.01 and the lowest listed price was 2.80 . The trading volume for the day was 511.2 K. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.38% . The overall trading delta against the current closing price is 16.16% . |
Cardiff Oncology Fundamentals Correlations and Trends
By evaluating Cardiff Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardiff Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardiff financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cardiff Oncology Stock history
Cardiff Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardiff is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardiff Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardiff Oncology stock prices may prove useful in developing a viable investing in Cardiff Oncology
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Cardiff Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.
Cardiff Oncology Stock Technical Analysis
Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cardiff Oncology Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Cardiff Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cardiff Oncology December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Cardiff Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiff Oncology shares will generate the highest return on investment. By undertsting and applying Cardiff Oncology stock market strength indicators, traders can identify Cardiff Oncology entry and exit signals to maximize returns
Cardiff Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardiff Oncology's price direction in advance. Along with the technical and fundamental analysis of Cardiff Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardiff to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0678 | |||
| Jensen Alpha | 0.3146 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | 0.0413 | |||
| Treynor Ratio | 0.4642 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |